Goldman lifts EQRx Inc. [EQRX] price estimate. Who else is bullish?


EQRx Inc. [NASDAQ: EQRX] surged by $0.21 during the normal trading session on Thursday and reaching a high of $4.76 during the day while it closed the day at $4.60. The company report on June 14, 2022 that EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Marketing authorization application is EQRx’s first submission to a regulatory agency.

Application is based on data from pivotal Phase 3 AENEAS trial in the first-line treatment of EGFR-mutated non-small cell lung cancer.

EQRx Inc. stock has also gained 12.20% of its value over the past 7 days. However, EQRX stock has inclined by 7.73% in the 3 months of the year. Over the past six months meanwhile, it has lost -51.93% and lost -32.55% year-on date.

The market cap for EQRX stock reached $2.32 billion, with 470.63 million shares outstanding and 407.76 million shares in the current float. Compared to the average trading volume of 1.62M shares, EQRX reached a trading volume of 3365124 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about EQRx Inc. [EQRX]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EQRX shares is $5.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EQRX stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for EQRx Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 13, 2022. While these analysts kept the previous recommendation, Cowen raised their target price to Outperform. The new note on the price target was released on April 22, 2022, representing the official price target for EQRx Inc. stock. Previously, the target price had yet another raise to $5.60, while Jefferies analysts kept a Buy rating on EQRX stock.

The Average True Range (ATR) for EQRx Inc. is set at 0.50 The Price to Book ratio for the last quarter was 1.40, with the Price to Cash per share for the same quarter was set at 3.21.

EQRX stock trade performance evaluation

EQRx Inc. [EQRX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.20. With this latest performance, EQRX shares dropped by -3.36% in over the last four-week period, additionally sinking by -51.93% over the last 6 months – not to mention a drop of -54.95% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EQRX stock in for the last two-week period is set at 52.25, with the RSI for the last a single of trading hit 54.07, and the three-weeks RSI is set at 51.67 for EQRx Inc. [EQRX]. The present Moving Average for the last 50 days of trading for this stock 4.46, while it was recorded at 4.10 for the last single week of trading, and 6.59 for the last 200 days.

EQRx Inc. [EQRX]: An insightful look at the core fundamentals

EQRx Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 29.20 and a Current Ratio set at 29.20.

EQRx Inc. [EQRX]: Insider Ownership positions

There are presently around $1,282 million, or 59.70% of EQRX stock, in the hands of institutional investors. The top three institutional holders of EQRX stocks are: SB MANAGEMENT LTD with ownership of 43,176,600, which is approximately 0% of the company’s market cap and around 5.90% of the total institutional ownership; CASDIN CAPITAL, LLC, holding 39,527,669 shares of the stock with an approximate value of $173.53 million in EQRX stocks shares; and ARCH VENTURE MANAGEMENT, LLC, currently with $159.51 million in EQRX stock with ownership of nearly 0% of the company’s market capitalization.

Positions in EQRx Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 56 institutional holders increased their position in EQRx Inc. [NASDAQ:EQRX] by around 29,292,996 shares. Additionally, 19 investors decreased positions by around 11,055,142 shares, while 26 investors held positions by with 251,708,839 shares. The mentioned changes placed institutional holdings at 292,056,977 shares, according to the latest SEC report filing. EQRX stock had 37 new institutional investments in for a total of 15,595,870 shares, while 11 institutional investors sold positions of 6,895,153 shares during the same period.